A study revealed a predominant cytoplasmic GPER expression in 189 primary invasive breast carcinomas (19.3%); a predominant nuclear GPER expression was observed in 529 cases (53.9%) [79]. This evidence concerns the gene GPER1 and invasive breast carcinoma.